Table 2.
The prevalence of prehospital medication according to fatal outcomes.
| Variables | n (%) 192 (100) |
Consumption time (days) |
Fatal result from COVID-19 |
|||
|---|---|---|---|---|---|---|
| media ±SD | median (range) | No 134 (69.8) |
Yes 58 (30.2) |
p-value* | ||
| ANTIMICROBIALS | ||||||
| Ivermectin | ||||||
| No | 145 (75.5) | 2.1 ± 0.9 | 2 (1–5) | 98 (67.6) | 47 (32.4) | 0.242 |
| Si | 47 (24.5) | 36 (76.6) | 11 (23.4) | |||
| Macrolides | ||||||
| No | 138 (71.9) | 3.6 ± 1.6 | 3 (0–8) | 91 (65.9) | 47 (34.1) | 0.063 |
| Si | 54 (28.1) | 43 (79.6) | 11 (20.4) | |||
| Ceftriaxone | ||||||
| No | 138 (71.9) | 3.7 ± 1.7 | 3 (1–8) | 101 (73.2) | 37 (26.8) | 0.101 |
| Si | 54 (28.1) | 33 (61.1) | 21 (38.9) | |||
| Other antibiotics | ||||||
| No | 147 (76.6) | 3.6 ± 1.7 | 3 (1–10) | 107 (72.8) | 40 (27.2) | 0.102 |
| Si | 45 (23.4) | 27 (60.0) | 18 (40.0) | |||
| Hydroxychloroquine | ||||||
| No | 190 (99.0) | 4 ± 1.4 | 4 (3–5) | 134 (70.5) | 56 (29.5) | 0.090 |
| Si | 2 (1.0) | 0 (0.0) | 2 (100.0) | |||
| CORTICOSTEROIDS | ||||||
| No | 124 (64.6) | 4.6 ± 5.0 | 3 (1–30) | 93 (75.0) | 31 (25.0) | 0.034 |
| Si | 68 (35.4) | 41 (60.3) | 27 (39.7) | |||
| COLCHICINE | ||||||
| No | 190 (99.0) | 4 ± 1.4 | 4 (3–5) | 134 (70.5) | 56 (29.5) | 0.090 |
| Si | 2 (1.0) | 0 (0.0) | 2 (100.0) | |||
| WARFARIN | ||||||
| No | 150 (78.1) | 3.4 ± 2.0 | 3 (1–8) | 112 (74.7) | 38 (25.3) | 0.005 |
| Si | 42 (21.9) | 22 (52.4) | 20 (47.6) | |||
| NSAIDS | ||||||
| Aspirin | ||||||
| No | 181 (94.3) | 5.2 ± 5.4 | 3 (1–20) | 126 (69.6) | 55 (30.4) | 0.827 |
| Si | 11 (5.7) | 8 (72.7) | 3 (27.3) | |||
| Other NSAIDs | ||||||
| No | 68 (35.4) | 4.6 ± 2.4 | 5 (1–12) | 47 (69.1) | 21 (30.9) | 0.880 |
| Si | 124 (64.6) | 87 (70.2) | 37 (29.8) | |||
| OTHER MEDICINES | ||||||
| Inhalers | ||||||
| No | 183 (95.3) | 5.1 ± 3.5 | 4 (3–14) | 130 (71.0) | 53 (29.0) | 0.090 |
| Si | 9 (4.7) | 4 (44.4) | 5 (55.6) | |||
| Antihistamines | ||||||
| No | 160 (83.3) | 3.6 ± 1.9 | 3 (1–8) | 111 (69.4) | 49 (30.6) | 0.779 |
| Si | 32 (16.7) | 23 (71.9) | 9 (28.1) | |||
| Acetylcysteine | ||||||
| No | 160 (83.3) | 4.2 ± 2.3 | 4 (1–12) | 115 (71.9) | 45 (28.1) | 0.160 |
| Si | 32 (16.7) | 19 (59.4) | 13 (40.6) | |||
| Vitamin C | ||||||
| No | 182 (94.8) | 6.1 ± 8.7 | 4 (1–30) | 126 (69.2) | 56 (30.8) | 0.470 |
| Si | 10 (5.2) | 8 (80.0) | 2 (20.0) | |||
| Vitamin D | ||||||
| No | 188 (97.9) | 4.8 ± 2.1 | 5 (2–7) | 131 (69.7) | 57 (30.3) | 1.000 |
| Si | 4 (2.1) | 3 (75.0) | 1 (25.0) | |||
| Zinc | ||||||
| No | 189 (98.4) | 11.3 ± 16.2 | 3 (1–30) | 131 (69.3) | 58 (30.7) | 0.555 |
| Si | 3 (1.6) | 3 (100.0) | 0 (0.0) | |||
| Chlorine Dioxide | ||||||
| No | 191 (99.5) | 2.0 ± 0.0 | . | 133 (69.6) | 58 (30.4) | 1.000 |
| Si | 1 (0.5) | 1 (100.0) | 0 (0.0) | |||
SD: standard deviation; NSAIDs: Nonsteroidal anti-inflammatory drugs.
Significant p-value of <0.05, found by chi-square test or Fisher test.